16
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Is Phencyclidine (PCP) Abuse Associated with Organic Mental Impairment?

, , &
Pages 273-281 | Published online: 07 Jul 2009

References

  • Burns R. S., Lerner S. E. Perspectives: Acute phencyclidine intoxication. Qin. Toxicol. 1976; 9: 477–501
  • Showalter C. V., Thornton W. E. The increasing abuse of phencyclidine. III. Med. J. 1977; 151: 387–389
  • Balster R. L., Pross R. S. Phencyclidine: A bibliography of biomedical and behavioral research. J. Psychedelic Drugs 1978; 10: 1–15
  • Fauman B., Aldinger G., Faumen M., Rosen P. Psychiatric sequelae of phencyclidine abuse. Qin. Toxicol. 1976; 9: 529–538
  • Cohen S. Angel dust. J. Am. Med. Assoc. 1977; 283: 515–516
  • Showalter C. V., Thornton W. E. Clinical pharmacology of phencyclidine toxicity. Am. J. Psychiatry 1977; 134: 1234–1238
  • Dorand R. D. Phencyclidine ingestion: Therapy review. South. Med. J. 1977; 70: 117–119
  • Rainey J. M., Crowder M. K. Prolonged psychosis attributed to phencyclidine: Report of three cases. Am. J. Psychiatry 1975; 132: 1076–1078
  • Grant I., Adams K. M., Carlin A. S., Rennick P. M., Judd L. L., Schooff K. The collaborative neuropsychological study of polydrug users. Arch. Gen. Psychiatry 1978; 35: 1063–1074
  • Adams K., Rennick P., Schooff K., Keegan J. Neuropsychological measurement of drug effects: Polydrug research. J. Psychedelic Drugs 1975; 7: 151–160
  • Grant I., Judd L. L. Neuropsychological and EEG disturbances in polydrug users. Am. J. Psychiatry 1976; 133: 1039–1042
  • Accord L. D. Hallucinogenic drugs and brain damage. Mil. Med. 1972; 137: 18–19
  • Accord L. D., Barker D. D. HaUuoinogogenic drugs and cerebrial deficit. J. Nerv. Ment. Dis. 1973; 156: 281–283
  • Cohen S., Edwards A. C. LSD and organic brain impairment. Drug Dependence 1969; 2: 1–4
  • McGlothlin W. H., Arnold D. O., Freedman D. X. Organicity measures following repeated LSD ingestion. Arch. Gen. Psychiatry 1969; 21: 704–709
  • Wright M., Hogan T. P. Repeated LSD ingestion and performance on neuro-physchological tests. J. Nerv. Ment. Dis. 1972; 154: 532–438
  • Luby E. D., Cohen B. D., Rosenbaum G., Gotlieb J. S., Kelley R. Study of a new schizophrenomimetic drug-Sernyl. Arch. Neurol. Psychiatry 1959; 81: 363–369
  • Bakker C. B., Amini F. B. Observations on the psychotometic effects of Sernyl. Compre. Psychiatry 1961; 2: 269–280
  • Beech H. R., Davies B. M., Morgenstem F. S. Preliminary investigation of the effects of Sernyl upon cognitive and sensory processes. J. Ment. Sci. 1961; 107: 509–513
  • Morgenstem F. S., Beech H. R., Davies B. M. An investigation of drug induced sensory disturbances. Psychopharmacologia 1962; 3: 193–201
  • Luby E. D., Gottlieb J. S., Cohen B. D., Rosenbaum G., Domino E. F. Model psychosis and schizophrenia. Am. J. Psychiatry 1962; 119: 61–67
  • Cohen B. D., Luby E. D., Rosenbaum G., Gottlieb J. S. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Arch. Gen. Psychiatry 1962; 6: 395–401
  • Domino E. F. Neurobilogy of phencyclidine (Semyl), a drug with an unusual spectrum of pharmacological activity. Neurobiology 1964; 6: 303–347

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.